← Eichor
Condition: Adv Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Adv Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Third Party Viral Specific T-cells (VSTs)
Phase 2 · 4 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02532452Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
Phase 1/Phase 2 · 2 location(s) · Catherine Bollard · NCT03594981A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Phase 3 · 81 location(s) · SymBio Pharmaceuticals · NCT07387367TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Phase 1 · 2 location(s) · Baylor College of Medicine · NCT04013802Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus S
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05101213A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
Phase 2 · 11 location(s) · SymBio Pharmaceuticals · NCT04706923Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Ce
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT05664126Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Beijing Neurosurgical Institute · NCT06585527Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
Phase 3 · 33 location(s) · Tobias Feuchtinger · NCT04832607Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab fo
EARLY_Phase 1 · 1 location(s) · Huashan Hospital · NCT07538128Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Phase 2 · 10 location(s) · New York Medical College · NCT03266627A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Phase 1 · 3 location(s) · Dispatch Biotherapeutics · NCT07544589Viral Infections in Healthy and Immunocompromised Hosts
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306084Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03159364Donor-Derived Viral Specific T-cells (VSTs)
Phase 1/Phase 2 · 3 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02048332Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Phase 2 · 67 location(s) · Synairgen Research Ltd. · NCT06999603Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation
EARLY_Phase 1 · 1 location(s) · Mari Dallas · NCT03378102R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Phase 1 · 1 location(s) · Columbia University · NCT06926894Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections
Phase 1/Phase 2 · 1 location(s) · Nationwide Children's Hospital · NCT04722029R-MVST Cells for Treatment of Viral Infections
Phase 1 · 1 location(s) · Columbia University · NCT05183490A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of He
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT02007356YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases
Phase 2 · 1 location(s) · Tianjin First Central Hospital · NCT07697937Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03878121The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunoco
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01011712Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With
Phase 1/Phase 2 · 3 location(s) · Jessie L. Alexander · NCT06909110
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.